Black Rock Inc. Merck & Co., Inc. Call Options Transaction History

Black Rock Inc.

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 13, 2024	SELL	$123.8 - $132.96 $204 Million - $219 Million	-1,649,500 Reduced 86.23%	263,400 $32.6 Million
Q1 2024 May 10, 2024	BUY	$113.24 - $131.95 $217 Million - $252 Million	1,912,900 New	1,912,900 $252 Million
Q2 2023 Aug 11, 2023	BUY	$108.61 - $118.38 $51.7 Million - $56.3 Million	476,000 New	476,000 $54.9 Million
Q4 2022 Feb 13, 2023	BUY	$87.44 - $112.11 $24.5 Million - $31.4 Million	280,000 New	280,000 $31.1 Million

3,827

1.87B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $248B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.